Nephros, Inc. NEPH
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 29.03% | 30.82% | -3.12% | 1,513.51% | 259.42% |
| Total Depreciation and Amortization | -13.38% | -11.89% | -8.39% | 5.11% | -7.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -14.08% | -7.66% | 12.63% | 15.75% | -10.83% |
| Change in Net Operating Assets | -43,188.89% | -605.30% | -71.37% | 56.37% | 100.36% |
| Cash from Operations | -133.47% | -133.10% | -169.32% | 434.35% | 233.74% |
| Capital Expenditure | -- | -- | -- | -- | 100.00% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -100.00% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | 100.00% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 0.00% | -100.00% | -25.00% | 0.00% | 28.57% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 5,800.00% | 9,566.67% | 7,225.00% | 0.00% | 28.57% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -123.03% | -118.91% | -114.06% | 399.82% | 225.36% |